These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36213358)

  • 1. Considerations of Competing Risks Analysis in Cardio-Oncology Studies:
    Li Y; Sun L; Burstein DS; Getz KD
    JACC CardioOncol; 2022 Sep; 4(3):287-301. PubMed ID: 36213358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications.
    Varadhan R; Weiss CO; Segal JB; Wu AW; Scharfstein D; Boyd C
    Med Care; 2010 Jun; 48(6 Suppl):S96-105. PubMed ID: 20473207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis.
    Schuster NA; Hoogendijk EO; Kok AAL; Twisk JWR; Heymans MW
    J Clin Epidemiol; 2020 Jun; 122():42-48. PubMed ID: 32165133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard and competing risk analysis of the effect of albuminuria on cardiovascular and cancer mortality in patients with type 2 diabetes mellitus.
    Feakins BG; McFadden EC; Farmer AJ; Stevens RJ
    Diagn Progn Res; 2018; 2():13. PubMed ID: 31093562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing risks analyses: objectives and approaches.
    Wolbers M; Koller MT; Stel VS; Schaer B; Jager KJ; Leffondré K; Heinze G
    Eur Heart J; 2014 Nov; 35(42):2936-41. PubMed ID: 24711436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of censoring in competing risks analysis of the subdistribution hazard.
    Donoghoe MW; Gebski V
    BMC Med Res Methodol; 2017 Apr; 17(1):52. PubMed ID: 28376736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations for analysis of time-to-event outcomes subject to competing risks in veterinary clinical studies.
    Oyama MA; Shaw PA; Ellenberg SS
    J Vet Cardiol; 2018 Jun; 20(3):143-153. PubMed ID: 29680637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to the Analysis of Survival Data in the Presence of Competing Risks.
    Austin PC; Lee DS; Fine JP
    Circulation; 2016 Feb; 133(6):601-9. PubMed ID: 26858290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of competing risks analysis improved prognostic assessment of patients with decompensated chronic heart failure and reduced left ventricular ejection fraction.
    Scrutinio D; Guida P; Passantino A; Ammirati E; Oliva F; Lagioia R; Frigerio M
    J Clin Epidemiol; 2018 Nov; 103():31-39. PubMed ID: 30009940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaplan-Meier Survival Analysis Overestimates the Risk of Revision Arthroplasty: A Meta-analysis.
    Lacny S; Wilson T; Clement F; Roberts DJ; Faris PD; Ghali WA; Marshall DA
    Clin Orthop Relat Res; 2015 Nov; 473(11):3431-42. PubMed ID: 25804881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. stpm2cr: A flexible parametric competing risks model using a direct likelihood approach for the cause-specific cumulative incidence function.
    Mozumder SI; Rutherford MJ; Lambert PC
    Stata J; 2017; 17(2):462-489. PubMed ID: 30305806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram for survival analysis in the presence of competing risks.
    Zhang Z; Geskus RB; Kattan MW; Zhang H; Liu T
    Ann Transl Med; 2017 Oct; 5(20):403. PubMed ID: 29152503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling competing risks in nephrology research: an example in peritoneal dialysis.
    Teixeira L; Rodrigues A; Carvalho MJ; Cabrita A; Mendonça D
    BMC Nephrol; 2013 May; 14():110. PubMed ID: 23705871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival analysis in the presence of competing risks.
    Zhang Z
    Ann Transl Med; 2017 Feb; 5(3):47. PubMed ID: 28251126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing Risks Methods Are Recommended for Estimating the Cumulative Incidence of Revision Arthroplasty for Health Care Planning Purposes.
    Lacny S; Faris P; Bohm E; Woodhouse LJ; Robertsson O; Marshall DA
    Orthopedics; 2021; 44(4):e549-e555. PubMed ID: 34292813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to Survival Analysis in the Presence of Competing Risks.
    Morita K
    Ann Clin Epidemiol; 2021; 3(4):97-100. PubMed ID: 38505470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.
    Austin PC; Steyerberg EW; Putter H
    Stat Med; 2021 Aug; 40(19):4200-4212. PubMed ID: 33969508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of competing risks flexible parametric modeling for estimation of the risk of the first disease among HIV infected men.
    Nouri S; Mahmoudi M; Mohammad K; Mansournia MA; Yaseri M; Akhtar-Danesh N
    BMC Med Res Methodol; 2020 Jan; 20(1):17. PubMed ID: 31996148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competing Risks Analysis of Kidney Transplant Waitlist Outcomes: Two Important Statistical Perspectives.
    Gaynor JJ; Guerra G; Vianna R; Tabbara MM; Graell EL; Ciancio G
    Kidney Int Rep; 2024 Jun; 9(6):1580-1589. PubMed ID: 38899174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use and interpretation of competing risks regression models.
    Dignam JJ; Zhang Q; Kocherginsky M
    Clin Cancer Res; 2012 Apr; 18(8):2301-8. PubMed ID: 22282466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.